Wet AMD 5 Symposium

Related

• 

  Potential Safety Concerns of Bevacizumab

  Robert L. Avery, MD

  Updates from the Field

  2017

• 

  Apples and Oranges: "Real-World" Outcomes Differ From Clinical Trial Outcomes Because "Real-World" Patients Differ From Clinical Trial Patients

  Franco M. Recchia, MD

  Annual Meeting Talks

  2021

• 

  Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA

  W. Lloyd Clark, MD, FASRS

  Annual Meeting Talks

  2019